Possibility of the use of Eudragit RS as a sustainedrelease matrix agent for the incorporation of watersoluble active compounds at high percentages

S.T.P. Pharma Sciences

Volumn 7, Issue 6, 1997, Pages 491-497

  Plaizier Vercammen, J ^a   Dauwe, D ^a   Brioen, P ^a  

^a PHARMACEUTICAL INSTITUTE   (Belgium)

Author keywords

Ammoniomethacrylate copolymer polyvinylpyrrolidone; Matrix tablet eudragit RS; Povidone; Quinine hydrochloride; Release rates optimization : Mixture design; Sustained release action

Indexed keywords

EUDRAGIT 30 D; EUDRAGIT RS; EUDRAGIT RS PO; POVIDONE; QUININE; UNCLASSIFIED DRUG;

ARTICLE; DRUG MIXTURE; DRUG SOLUBILITY; MATRIX TABLET; REGRESSION ANALYSIS; SUSTAINED DRUG RELEASE; TABLET COMPRESSION; TABLET FORMULATION; TABLET MANUFACTURE;

EID: 0031543993     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. LEHMANN K. - Fluid-bed spray coating. - In : Microcapsules and Nanoparticles in Medicine and Pharmacy, Chapter 4, M. Donbrow Ed., CRC Press, Inc., Boca Raton, 1992.
2. BAUER K., LEHMANN K., OSTERWALD H. and ROTHGANG G. - Coated Pharmaceutical Dosage Forms. -Wissenschaftliche Verlagsgesellschaft, Stuttgart, 1988.
3. LEHMANN K. et al. - Practical course in film coating of pharmaceutical dosage forms with Eudragit. - Rohm GmbH, 1996.
4. LEHMANN K. - Coating of multiparticulates using polymeric solutions. - In : Multiparticulate Oral Drug Delivery, Chapter 4, I. Ghebre-Sellassie Ed., Marcel Dekker, Inc., New York, 1994.
5. LEHMANN K. - Chemistry and application properties of polymethacrylate coating systems. - In : Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms, Chapter 4, J.W. McGinity Ed., Marcel Dekker, New York, 1989.
6. LEHMANN K. and PETEREIT H.U. - Film coatings based on aqueous polymethacrylate dispersions for sustained-release in the intestinal tract. -Drugs Made in Germany, 37,19-21,1994.
7. CAMERON C.L. and McGINITY J.W. - Controlled-release theophylline tablet formulations containing acrylic resins. Ill : Influence of filler excipient. - Drug Dev. Ind. Pharm., 13, 303318, 1987.
8. GURNASINGHANI M. - Indomethacin delivery controlledrelease indomethacin tablet. - J. Contr. Release, 8, 221-222, 1989.
9. VILA JATO J.L., LLABRES M., MARTINEZ-PACH R. and CONCHEIRO A. - La biodisponibilité. Etude critique et perspectives futures. - Labo Pharm. Probl. Techn., 30, 155161, 1982.
10. RAHMAN A., EMAN M., SAYED I, RAHMAN A., ABOUTALEB A. and STAMM A. - Evaluation of ibuprofen controlled-release tablets. I : Eudragit matrix controlled-release tablets. - Eur. J. Pharm. Biopharm., 38, 71-77, 1992
11. BUCKTON G., EFENTAKIS M. and HUSSAIN Z. - Modelling drug release from matrix formulation by use of thermodynamic activation parameters and extrathermodynamic. - Eur. J. Pharm. Biopharm., 37, 154-158, 1991.
12. ALVAREZA., VILLAFUERTEM., FERNANDEZ-AREVALOM. and DORADO J. - Inert matrix tablet as controlled release dosage form for Carteol.HCI. - Eur. J. Pharm. Bioph., 37,147153,1991.
13. CLARINGBOLD F. - Use of the simplex design in the study of the joint action of related hormones. - Biometrics, 11,174-185, 1955.
14. SCHEFFÉ H. - Experiments with mixtures. - Journal of the Royal Statistical Society, Series B, 20, 344-360, 1958.
15. SNEE R. - Design and analysis of mixture experiments. Journal of Quality Technology, 3, 159-169, 1971.
16. HUiSMAN R., VAN KAMP H., WEYLAND J., DOORNBOS D BOLHUIS G. and LERK F. - Development and optimization of pharmaceutical formulations using a simplex lattice design. Pharmaceutisch Weekblad, 6, 185-194, 1984
17. CORNELL J. - Experiments with Mixtures. - Wiley and Sons, New York, 1990, p. 52.
18. KOCH H. - Die Technik der Dissolutionsbestimmung, Teil 3. Pharm. Acta Helv., 39, 178-190, 1984.
19. LANGENBUCHER F. - Linearization of dissolution rate curves by the Weibull distribution. - J. Pharm. Pharmac., 24, 979 - 981, 1972
20. LEFORT DES YLOUSES D. and BROSSARD C.- Matrices à action prolongée. - Sei. Techn. Pharm., 6, 341-345, 1976.
21. DESAI S., SINGH P., SIMONELLI P. and HIGUCHI W. Investigation of factors influencing release of solid drug dispersed in inert matrices. Ill : Quantitative studies involving the polyethylene plastic matrix. - J. Pharm. Sei., 55, 1230-1234, 1966.
22. REER O. and MÜLLER B. - Investigation of the influence of cosolvents and surfactants on the complexation of dexamethasone with hydroxypropyl-cylcodextrin by use of a simplex lattice design. - Eur. J. Pharm. Biopharm., 39,105-111, 1993.